We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+7.8%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.8B
AUM Growth
+$2.96B
(+8.3%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
12.28%
Holding
2,861
New
368
Increased
965
Reduced
1,202
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$401M |
| 2 |
Netflix
NFLX
|
+$388M |
| 3 |
Ford
F
|
+$340M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$330M |
| 5 |
Boeing
BA
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$391M |
| 2 |
TSMC
TSM
|
+$387M |
| 3 |
Oracle
ORCL
|
+$282M |
| 4 |
Advanced Micro Devices
AMD
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$247M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.93% |
| 2 | Healthcare | 17.44% |
| 3 | Industrials | 12.95% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Financials | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRML
2451
DELISTED
Tourmaline Bio
TRML
| $47.9K | ﹤0.01% |
2,550
-820
| -24% | -$13.5K |
|
2452
CleanSpark
CLSK
$3.46B
| $47.8K | ﹤0.01% |
+17,200
| New | +$47.2K |
|
|
CYT
2453
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $47.3K | ﹤0.01% |
26,000
| – | – |
|
2454
OmniAb
OABI
$286M
| $47.3K | ﹤0.01% |
12,850
+1,100
| +9% | +$4.15K |
|
|
EQRX
2455
DELISTED
EQRx, Inc. Common Stock
EQRX
| $46.9K | ﹤0.01% |
+24,200
| New | +$55.1K |
|
2456
INNOVATE Corp
VATE
$106M
| $46.5K | ﹤0.01% |
1,565
+395
| +34% | +$11.5K |
|
2457
Cumberland Pharmaceuticals
CPIX
$102M
| $46.2K | ﹤0.01% |
23,700
-800
| -3% | -$1.9K |
|
|
NAGE
2458
Niagen Bioscience
NAGE
$262M
| $46.1K | ﹤0.01% |
30,100
-19,100
| -39% | -$34K |
|
|
ZH
2459
Zhihu
ZH
$281M
| $45.8K | ﹤0.01% |
6,017
+4,284
| +247% | +$39.7K |
|
|
PLG
2460
Platinum Group Metals
PLG
$159M
| $45.2K | ﹤0.01% |
31,600
-31,000
| -50% | -$47K |
|
|
APTO
2461
DELISTED
Aptose Biosciences, Inc.
APTO
| $45.1K | ﹤0.01% |
157
-96
| -38% | -$27.9K |
|
|
LTRPA
2462
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $44.8K | ﹤0.01% |
52,180
-37,620
| -42% | -$41.1K |
|
2463
Playboy Inc
PLBY
$141M
| $44.7K | ﹤0.01% |
+22,600
| New | +$56.2K |
|
2464
Atossa Therapeutics
ATOS
$24.1M
| $44.1K | ﹤0.01% |
4,053
-2,054
| -34% | -$22.9K |
|
2465
Brilliant Earth
BRLT
$18.4M
| $43K | ﹤0.01% |
11,000
-2,500
| -19% | -$11.6K |
|
2466
Lipocine
LPCN
$17.6M
| $42K | ﹤0.01% |
7,765
-1,794
| -19% | -$13.9K |
|
2467
Protalix BioTherapeutics
PLX
$188M
| $41.8K | ﹤0.01% |
19,900
-700
| -3% | -$1.23K |
|
|
ASTR
2468
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $41.3K | ﹤0.01% |
6,480
+2,393
| +59% | +$19K |
|
2469
GrowGeneration
GRWG
$88.3M
| $41K | ﹤0.01% |
+12,000
| New | +$51.3K |
|
|
HEPS
2470
D-Market Electronic Services & Trading
HEPS
$1.06B
| $40.9K | ﹤0.01% |
30,500
+11,800
| +63% | +$11.6K |
|
2471
Regis Corp
RGS
$68.2M
| $40K | ﹤0.01% |
1,800
-375
| -17% | -$10.4K |
|
|
AIFA
2472
All In FutureTech Alliance Inc
AIFA
$11.4M
| $39.8K | ﹤0.01% |
5,500
-633
| -10% | -$4.78K |
|
|
FTH
2473
Faeth Therapeutics
FTH
$751M
| $39.5K | ﹤0.01% |
1,315
-455
| -26% | -$13.5K |
|
|
TRVG
2474
trivago
TRVG
$387M
| $39.4K | ﹤0.01% |
5,220
+1,860
| +55% | +$15.2K |
|
|
NEUE
2475
DELISTED
NeueHealth
NEUE
| $38.4K | ﹤0.01% |
2,181
+1,070
| +96% | +$55.1K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, Two Sigma Advisers held 2,861 positions worth $38.8B, up 8.3% from $35.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Two Sigma Advisers's Q1 2023 filing shows 368 new, 965 increased, 1,202 reduced and 293 closed positions. Its largest new stake was Netflix: 11,730,000 shares worth $405M. The largest sale was Tesla, an estimated $391M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
- Two Sigma Advisers's largest Q1 2023 buy was Netflix: 11,730,000 shares worth $405M.
- Two Sigma Advisers added most to CVS Health in Q1 2023, an estimated $401M increase.
- Two Sigma Advisers's biggest Q1 2023 reduction was TSMC, cutting an estimated $387M.
- Two Sigma Advisers fully exited Tesla in Q1 2023, selling an estimated $391M.
- Two Sigma Advisers's ten largest holdings make up 12% of its $38.8B portfolio in Q1 2023.
- Two Sigma Advisers opened 368 new positions and closed 293 in Q1 2023.
- Two Sigma Advisers's portfolio value rose 8.3% quarter-over-quarter to $38.8B.
Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.